Compounds > 3-(2,2,2-trimethylhydrazine)propionate
Page last updated: 2024-09-03

3-(2,2,2-trimethylhydrazine)propionate and Arrhythmia

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Arrhythmia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grigoryan, SV; Hazarapetyan, LG; Stepanyan, AA1
Cirule, H; Dambrova, M; Kalvinsh, I; Kuka, J; Liepinsh, E; Veveris, M; Vilskersts, R1

Other Studies

2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Arrhythmia

ArticleYear
[An Experience of Meldonium Use in Patients with Ventricular Arrhythmias of Ischemic Genesis].
    Kardiologiia, 2019, Jul-19, Volume: 59, Issue:7

    Topics: Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Humans; Methylhydrazines; Quality of Life

2019
Myocardial infarct size-limiting and anti-arrhythmic effects of mildronate orotate in the rat heart.
    Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:4

    Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Male; Methylhydrazines; Myocardial Infarction; Necrosis; Orotic Acid; Rats; Rats, Wistar; Reperfusion Injury

2009